References
- JagerRDMielerWFMillerJWAge-related macular degenerationN Engl J Med2008358242606261718550876
- TaCNMinimizing the risk of endophthalmitis following intravitreous injectionsRetina200424569970515492622
- AielloLPBruckerAJChangSEvolving guidelines for intravitreous injectionsRetina2004245 supplS3S1915483476
- AnijeetDRHansonRJBhageyJBatesRANational survey of the technique of intravitreal triamcinolone injection in the United KingdomEye200721448048616440019
- HuangKSultanMBZhouDOcular safety of intravitreal injections of age-related macular degeneration treatments in a prospective observational cohort study in EuropeJ Clin Res Ophthalmol20153115
- Green-SimmsAEEkdawiNSBakriSJSurvey of intravitreal injection techniques among retinal specialists in the United StatesAm J Ophthalmol2011151232933221168821
- XingLDorrepaalSJGaleJSurvey of intravitreal injection techniques and treatment protocols among retina specialists in CanadaCan J Ophthalmol201449326126624862772
- HuangKSultanMBZhouDTresslerCSMoJSpecial Issue: Abstracts of the 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Taipei, Taiwan, October 24–27, 2014Pharmacoepidemiol Drug Saf201423S1149725267011